For the Inventor, By the Inventor

Enter assignee name

Columbia, MD, United States of America

Osiris Therapeutics, Inc.

USPTO Granted Patents = 72

% Expired Patents = 8.3

CIPO Patents = 1

EPO Patents = 17

Trademarks = 11

Forward Citations = 6,050

Loading Chart...

Loading Chart...

75 inventors (with patents filed for the assignee):

Alla Danilkovitch (29 out of 38 patents)

Jin-Qiang Kuang (25 out of 26 patents)

Dana Sue Yoo (19 out of 19 patents)

4. Samson Tom (19 out of 25 patents)

5. Timothy Jansen (15 out of 15 patents)

6. Jennifer Michelle Marconi (14 out of 14 patents)

7. Mark F Pittenger (9 out of 23 patents)

8. Joseph D Mosca (9 out of 11 patents)

9. Kevin R McIntosh (8 out of 9 patents)

10. Scott Philip Bruder (8 out of 10 patents)

11. Arnold I Caplan (7 out of 22 patents)

12. Elena N Klyushnenkova (6 out of 7 patents)

13. Stephen E Haynesworth (6 out of 13 patents)

14. Stephen L Gordon (5 out of 19 patents)

15. Alastair Morgan Mackay (5 out of 11 patents)

Core Competencies:

Mesenchymal Stem Cells

Immunocompatible Membranes

Tissue Regeneration

Bone Repair

Cartilage Products

Vitalized Placental Dispersions

Human Tissue Compositions

Adipogenic Differentiation

Hematopoietic Stem Cells

Wound Treatment

Immune Response Suppression

Cardiac Muscle Regeneration

72 patents: Sort by Forward Citations

1. 12558377 - Immunocompatible chorionic membrane products (2026-02-24),

2. 12343446 - Bone repair product and methods of use thereof (2025-07-01),

3. 12318408 - Methods of manufacture of therapeutic products comprising vitalized placental dispersions (2025-06-03),

4. 12310993 - Human tissue derived compositions and uses thereof (2025-05-27),

5. 12268797 - Non-cultured, partially digested, cryopreserved cartilage product (2025-04-08),

6. 12109241 - Methods of manufacture of immunocompatible chorionic membrane products (2024-10-08),

7. 11986498 - Therapeutic products comprising vitalized placental dispersions (2024-05-21),

8. 11638725 - Methods of manufacture of immunocompatible chorionic membrane products (2023-05-02),

9. 11590173 - Methods of manufacture of therapeutic products comprising vitalized placental dispersions (2023-02-28),

10. 11590172 - Immunocompatible chorionic membrane products (2023-02-28),

11. 11510947 - Methods of manufacture of immunocompatible amniotic membrane products (2022-11-29),

12. 11464809 - Umbilical tissue compositions and methods of use (2022-10-11),

13. 11413373 - Disrupted cartilage products (2022-08-16),

14. 11406735 - Methods of manufacturing cartilage products (2022-08-09),

15. 11318168 - Human tissue derived compositions and uses thereof (2022-05-03),

Company Overview

Osiris Therapeutics, Inc., based in Columbia, MD, specializes in the development and commercialization of innovative therapies utilizing mesenchymal stem cells. The company focuses on advanced technologies for tissue regeneration, including immunocompatible membranes and products for bone and cartilage repair. With a commitment to enhancing human health, Osiris is dedicated to creating vitalized placental dispersions and human tissue compositions that support adipogenic differentiation and promote healing in various medical applications.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

72 Patents

#6 in Columbia, MD

#44 in Maryland

#5,108 in US

#10,396 in the World

Columbia, MD, United States of America

Osiris Therapeutics, Inc.

Forward Citations = 6,050

75 inventors:

Alla Danilkovitch (29 out of 38 patents)

Jin-Qiang Kuang (25 out of 26 patents)

Dana Sue Yoo (19 out of 19 patents)

4. Samson Tom (19 out of 25 patents)

5. Timothy Jansen (15 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Osiris Therapeutics, Inc.. Retrieved from https://idiyas.com/company/osiris-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…